RT Journal Article
SR Electronic
T1 Prescribing for Women in Corrections
JF Journal of the American Academy of Psychiatry and the Law Online
JO J Am Acad Psychiatry Law
FD American Academy of Psychiatry and the Law
SP 476
OP 485
DO 10.29158/JAAPL.003885-19
VO 47
IS 4
A1 Susan Hatters Friedman
A1 Anthony C. Tamburello
A1 Aimee Kaempf
A1 Ryan C.W. Hall
YR 2019
UL http://jaapl.org/content/47/4/476.abstract
AB Prescribing for women in jails and prisons requires special consideration and should be informed by extant evidence. Incarcerated women have higher rates of mental illness than both females in the community and incarcerated men. Medication administration concerns that may disproportionately affect female prisoners include drug–drug interactions with contraceptives, intermittent dosing schedules, and concerns about metabolic side effects. Further, pregnancy, lactation, and menopause may all affect medication choices. Incarcerated women frequently have comorbid mental illness, substance use disorders, and personality disorders. Finally, specific disorders, such as posttraumatic stress disorder, are more common in this population and merit special consideration for recognition and treatment.